Please Wait.....
Report
Cardiac Safety Services Market by Type (Standalone, Integrated), Services (ECG/Holter measurement, Blood Pressure measurement, Cardiac Imaging, Thorough QT Studies), End User (Pharmaceutical, Biopharma, CROs), Region - Global Forecast to 2027
Market Report I 2022-08-25 I 128 Pages I MarketsandMarkets
The cardiac safety services market is projected to reach USD 1.0 Billion by 2027 from USD 0.6 Billion in 2022, at a CAGR of 11.2% during the forecast period. The increasing expenditure by pharmaceutical companies, alongside rising government spending is leading has driven the pace of R&D activity in this industry to develop new drugs. This will contribute to the need for numerous preclinical and clinical services during drug development, including cardiac safety evaluation.
"The Blood Pressure Measurement segment accounted for the second largest share of the type of services market in 2021"
Blood pressure monitoring is an essential part of cardiac safety services. Increasing R&D activities and stringent clinical trial regulations make blood pressure measurement a critical parameter from both an efficacy and a safety endpoint. This factor is expected to drive the growth of this market segment.
"The contract research organizations (CROs) accounted for the second largest share of the end user market in 2021"
CROs provide specialized services to pharmaceutical & biopharmaceutical companies at a low cost. As a result, many pharmaceutical & biopharmaceutical companies are outsourcing their drug discovery services to CROs. As cardiac safety services are critical in drug development processes, their adoption is expected to increase with an increase in outsourcing
Laboratory Corporation of America Holdings (US), Koninklijke Philips N.V. (Netherlands), Clario (US), Banook Group (France), IQVIA (US), Biotrial (France), Certara (US), Celerion (US), Medpace (US), Ncardia (Netherlands), Richmond Pharmacology (UK), PhysioStim (France), Shanghai Medicilon (China), Pharmaceutical Product Development (US), and SGS (Switzerland) are some of the major players operating in the market.
"Europe: The second largest share in the cardiac safety services market"
The European market includes Germany, the UK, France, Italy, Spain, and the RoE. It accounted for the second largest market share of the cardiac safety services market. Important considerations include demographic changes, such as the growing incidence of chronic diseases is expected to drive the market growth in the region
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 80% and Demand Side - 20%
- By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%
- By Region: North America -20%, Europe -10%, Asia-Pacific -55%, RoW -15%
List of Companies Profiled in the Report:
- Laboratory Corporation of America Holdings (US)
- Koninklijke Philips N.V. (Netherlands)
- Clario (US)
- Banook Group (France)
- IQVIA (US)
- Biotrial (France)
- Certara (US)
- Celerion (US)
- Medpace (US)
- Ncardia (Netherlands)
- Richmond Pharmacology (UK)
- PhysioStim (France)
- Shanghai Medicilon (China)
- Pharmaceutical Product Development (US)
- SGS (Switzerland)
Research Coverage:
This report provides a detailed picture of the cardiac safety services market. It aims at estimating the size and future growth potential of the market across different segments such as the type, type of service, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cardiac safety services market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, challenges, trends, and opportunities.
1 INTRODUCTION 20
1.1 STUDY OBJECTIVES 20
1.2 MARKET DEFINITION 20
1.3 STUDY SCOPE 21
FIGURE 1 CARDIAC SAFETY SERVICES MARKET 21
1.4 YEARS CONSIDERED 21
1.5 CURRENCY CONSIDERED 22
1.6 LIMITATIONS 22
1.7 STAKEHOLDERS 22
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH DATA 23
FIGURE 2 RESEARCH DESIGN 23
2.1.1 SECONDARY DATA 23
2.1.1.1 Key data from secondary sources 24
2.1.2 PRIMARY DATA 25
2.1.2.1 Key data from primary sources 25
2.1.2.2 Key industry insights 26
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 26
2.2 MARKET SIZE ESTIMATION 27
2.2.1 BOTTOM-UP APPROACH 27
FIGURE 4 BOTTOM-UP APPROACH 27
2.2.2 TOP-DOWN APPROACH 28
FIGURE 5 TOP-DOWN APPROACH 28
2.2.3 GROWTH FORECAST 28
2.3 DATA TRIANGULATION 29
FIGURE 6 DATA TRIANGULATION METHODOLOGY 29
2.4 RESEARCH ASSUMPTIONS 30
3 EXECUTIVE SUMMARY 31
FIGURE 7 CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2022 VS. 2027 (USD MILLION) 31
FIGURE 8 CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 32
FIGURE 9 CARDIAC SAFETY SERVICES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 32
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF CARDIAC SAFETY SERVICES MARKET 33
4 PREMIUM INSIGHTS 34
4.1 CARDIAC SAFETY SERVICES MARKET OVERVIEW 34
FIGURE 11 INCREASING NUMBER OF CLINICAL TRIALS TO DRIVE MARKET GROWTH 34
4.2 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET SHARE, BY TYPE AND COUNTRY (2021) 35
FIGURE 12 INTEGRATED SERVICES ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2021 35
4.3 CARDIAC SAFETY SERVICES MARKET SHARE, BY TYPE OF SERVICE, 2022 VS. 2027 36
FIGURE 13 ECG/HOLTER MEASUREMENT SERVICES SEGMENT TO DOMINATE MARKET IN 2027 36
4.4 CARDIAC SAFETY SERVICES MARKET SHARE, BY END USER, 2022 36
FIGURE 14 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022 36
4.5 CARDIAC SAFETY SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 37
FIGURE 15 EUROPEAN COUNTRIES TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 37
5 MARKET OVERVIEW 38
5.1 INTRODUCTION 38
5.2 MARKET DYNAMICS 38
FIGURE 16 CARDIAC SAFETY SERVICES MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES 38
5.2.1 DRIVERS 39
5.2.1.1 Growing R&D expenditure in pharmaceutical & biopharmaceutical industry 39
FIGURE 17 GLOBAL PHARMACEUTICAL R&D SPENDING, 2012-2026 39
5.2.1.2 Increased outsourcing of R&D activities 39
FIGURE 18 ACTIVE PHARMACEUTICAL DRUG PIPELINE, JANUARY 2011 TO JANUARY 2021 40
5.2.1.3 Increasing number of clinical trials 40
FIGURE 19 INCREASING NUMBER OF CLINICAL TRIALS REGISTERED WORLDWIDE (2000-2021) 41
5.2.2 OPPORTUNITIES 41
5.2.2.1 Introduction of new technologies and methods 41
5.2.2.2 Growth in biosimilars and biologics markets 42
5.2.3 CHALLENGES 42
5.2.3.1 High cost of cardiac safety evaluation 42
6 CARDIAC SAFETY SERVICES MARKET, BY TYPE 43
6.1 INTRODUCTION 44
TABLE 1 CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 44
6.2 INTEGRATED SERVICES 44
6.2.1 INTEGRATED SERVICES TO DOMINATE CARDIAC SAFETY SERVICES MARKET 44
TABLE 2 INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 44
TABLE 3 NORTH AMERICA: INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 45
TABLE 4 EUROPE: INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 45
TABLE 5 ASIA PACIFIC: INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 46
6.3 STANDALONE SERVICES 46
6.3.1 STANDALONE SERVICES SEGMENT WITNESSING GROWTH DUE TO COST-EFFECTIVENESS 46
TABLE 6 STANDALONE CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 46
TABLE 7 NORTH AMERICA: STANDALONE CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 47
TABLE 8 EUROPE: STANDALONE CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 47
TABLE 9 ASIA PACIFIC: STANDALONE CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 48
7 CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE 49
7.1 INTRODUCTION 50
TABLE 10 CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 50
7.2 ECG/HOLTER MEASUREMENT SERVICES 50
7.2.1 ECG/HOLTER MEASUREMENT SERVICES SUPPORT R&D IN NOVEL METHODS FOR CLINICAL TRIALS AND DRUG DISCOVERY 50
TABLE 11 ECG/HOLTER MEASUREMENT SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 51
TABLE 12 NORTH AMERICA: ECG/HOLTER MEASUREMENT SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 51
TABLE 13 EUROPE: ECG/HOLTER MEASUREMENT SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 51
TABLE 14 ASIA PACIFIC: ECG/HOLTER MEASUREMENT SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 52
7.3 BLOOD PRESSURE MEASUREMENT SERVICES 52
7.3.1 INCREASING R&D ACTIVITIES TO DRIVE MARKET GROWTH 52
TABLE 15 BLOOD PRESSURE MEASUREMENT SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 52
TABLE 16 NORTH AMERICA: BLOOD PRESSURE MEASUREMENT SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 53
TABLE 17 EUROPE: BLOOD PRESSURE MEASUREMENT SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 53
TABLE 18 ASIA PACIFIC: BLOOD PRESSURE MEASUREMENT SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 53
7.4 CARDIOVASCULAR IMAGING SERVICES 54
7.4.1 CARDIOVASCULAR IMAGING SERVICES HELP IN DRUG EVALUATION 54
TABLE 19 CARDIOVASCULAR IMAGING SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 54
TABLE 20 NORTH AMERICA: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 54
TABLE 21 EUROPE: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 55
TABLE 22 ASIA PACIFIC: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 55
7.5 THOROUGH QT STUDIES 55
7.5.1 NEED TO MEET STRINGENT REGULATORY REQUIREMENTS TO DRIVE DEMAND FOR THOROUGH QT STUDIES 55
TABLE 23 THOROUGH QT STUDIES MARKET, BY REGION, 2020-2027 (USD MILLION) 56
TABLE 24 NORTH AMERICA: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 56
TABLE 25 EUROPE: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 57
TABLE 26 ASIA PACIFIC: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 57
7.6 OTHER SERVICES 58
TABLE 27 OTHER CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 58
TABLE 28 NORTH AMERICA: OTHER CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 58
TABLE 29 EUROPE: OTHER CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 59
TABLE 30 ASIA PACIFIC: OTHER CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 59
8 CARDIAC SAFETY SERVICES MARKET, BY END USER 60
8.1 INTRODUCTION 61
TABLE 31 CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 61
8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 61
8.2.1 INCREASING R&D BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO DRIVE DEMAND FOR CARDIAC SAFETY SERVICES 61
TABLE 32 CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020-2027 (USD MILLION) 62
TABLE 33 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION) 62
TABLE 34 EUROPE: CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION) 62
TABLE 35 ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION) 63
8.3 CONTRACT RESEARCH ORGANIZATIONS 63
8.3.1 INCREASING OUTSOURCING OF DRUG DISCOVERY PROCESSES TO SUPPORT SEGMENT GROWTH 63
TABLE 36 CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2020-2027 (USD MILLION) 63
TABLE 37 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020-2027 (USD MILLION) 64
TABLE 38 EUROPE: CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020-2027 (USD MILLION) 64
TABLE 39 ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020-2027 (USD MILLION) 65
9 CARDIAC SAFETY SERVICES MARKET, BY REGION 66
9.1 INTRODUCTION 67
TABLE 40 CARDIAC SAFETY SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 67
9.2 NORTH AMERICA 67
FIGURE 20 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET SNAPSHOT 68
TABLE 41 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 69
TABLE 42 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 69
TABLE 43 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 69
TABLE 44 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 70
9.2.1 US 70
9.2.1.1 US dominates global cardiac safety services market 70
TABLE 45 US: TOTAL NUMBER OF CLINICAL TRIALS (2019) 70
TABLE 46 US: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 71
TABLE 47 US: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 71
TABLE 48 US: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 71
9.2.2 CANADA 72
9.2.2.1 Canada has high-quality clinical trial infrastructure and expertise 72
TABLE 49 CANADA: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 72
TABLE 50 CANADA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 73
TABLE 51 CANADA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 73
9.3 EUROPE 73
FIGURE 21 EUROPE: CARDIAC SAFETY SERVICES MARKET SNAPSHOT 74
TABLE 52 EUROPE: CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 75
TABLE 53 EUROPE: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 75
TABLE 54 EUROPE: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 75
TABLE 55 EUROPE: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 76
9.3.1 GERMANY 76
9.3.1.1 Availability of skilled staff and flexible labor laws have made Germany a popular EU hub for clinical trials 76
TABLE 56 GERMANY: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 77
TABLE 57 GERMANY: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 77
TABLE 58 GERMANY: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 77
9.3.2 UK 78
9.3.2.1 Steady growth of pharmaceutical R&D expenditure indicates favorable prospects for cardiac safety services 78
TABLE 59 UK: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 78
TABLE 60 UK: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 79
TABLE 61 UK: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 79
9.3.3 FRANCE 79
9.3.3.1 High clinical trial activity for cancer therapies to drive market growth 79
TABLE 62 FRANCE: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 80
TABLE 63 FRANCE: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 80
TABLE 64 FRANCE: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 80
9.3.4 ITALY 81
9.3.4.1 Strong pharma industry and availability of funding for drug development fuel market growth 81
TABLE 65 NUMBER OF CLINICAL TRIALS STARTED IN ITALY, BY COMPANY (JANUARY 2021) 81
TABLE 66 ITALY: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 82
TABLE 67 ITALY: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 82
TABLE 68 ITALY: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 82
9.3.5 SPAIN 83
9.3.5.1 Growing investment in pharmaceutical R&D and a favorable climate for approvals boost market growth 83
TABLE 69 SPAIN: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 83
TABLE 70 SPAIN: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 84
TABLE 71 SPAIN: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 84
9.3.6 REST OF EUROPE 84
TABLE 72 ROE: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 85
TABLE 73 ROE: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 85
TABLE 74 ROE: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 86
9.4 ASIA PACIFIC 86
TABLE 75 APAC: CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 87
TABLE 76 APAC: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 87
TABLE 77 APAC: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 87
TABLE 78 APAC: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 88
9.4.1 CHINA 88
9.4.1.1 China dominates APAC market for cardiac safety services 88
TABLE 79 CHINA: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 88
TABLE 80 CHINA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 89
TABLE 81 CHINA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 89
9.4.2 JAPAN 89
9.4.2.1 Strong IP rights and supportive policies have strengthened R&D sector in Japan 89
TABLE 82 JAPAN: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 90
TABLE 83 JAPAN: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 90
TABLE 84 JAPAN: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 90
9.4.3 INDIA 91
9.4.3.1 Lack of language barriers and availability of trained resources make India an attractive destination for clinical trials 91
TABLE 85 INDIA: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 91
TABLE 86 INDIA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 91
TABLE 87 INDIA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 92
9.4.4 AUSTRALIA 92
9.4.4.1 Favorable R&D tax incentives and cash rebates have driven clinical trial activity in Australia 92
TABLE 88 AUSTRALIA: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 92
TABLE 89 AUSTRALIA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 93
TABLE 90 AUSTRALIA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 93
9.4.5 REST OF ASIA PACIFIC 93
TABLE 91 ROAPAC: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 94
TABLE 92 ROAPAC: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 94
TABLE 93 ROAPAC: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 94
9.5 REST OF THE WORLD 95
TABLE 94 ROW: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2020-2027 (USD MILLION) 96
TABLE 95 ROW: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 96
TABLE 96 ROW: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 96
10 COMPETITIVE LANDSCAPE 97
10.1 OVERVIEW 97
FIGURE 22 KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM 2019-2022 97
10.2 MARKET PLAYER RANKING 98
TABLE 97 GLOBAL CARDIAC SAFETY SERVICES MARKET PLAYER RANKING, 2021 98
10.3 COMPETITIVE LEADERSHIP MAPPING 99
10.3.1 VISIONARY LEADERS 99
10.3.2 DYNAMIC DIFFERENTIATORS 99
10.3.3 INNOVATORS 99
10.3.4 EMERGING COMPANIES 99
FIGURE 23 CARDIAC SAFETY SERVICES MARKET: COMPETITIVE LEADERSHIP MAPPING 100
10.4 COMPETITIVE SITUATION AND TRENDS 101
10.4.1 ACQUISITIONS 101
TABLE 98 ACQUISITIONS, 2019-2022 101
10.4.2 PARTNERSHIPS, ALLIANCES, AND AGREEMENTS 101
TABLE 99 PARTNERSHIPS, ALLIANCES, AND AGREEMENTS, 2019-2022 101
10.4.3 EXPANSIONS 101
TABLE 100 EXPANSIONS, 2019-2022 101
10.4.4 OTHER STRATEGIES 102
TABLE 101 OTHER STRATEGIES, 2019-2022 102
?
11 COMPANY PROFILES 103
(Business overview, Products offered, Recent Developments, MNM view)*
11.1 KEY PLAYERS 103
11.1.1 LABORATORY CORPORATION OF AMERICA HOLDINGS 103
TABLE 102 LABORATORY CORPORATION OF AMERICA HOLDINGS: BUSINESS OVERVIEW 103
FIGURE 24 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT 104
11.1.2 KONINKLIJKE PHILIPS 106
TABLE 103 KONINKLIJKE PHILIPS: BUSINESS OVERVIEW 106
FIGURE 25 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT 107
11.1.3 CLARIO 109
TABLE 104 CLARIO: BUSINESS OVERVIEW 109
11.1.4 BANOOK GROUP 111
TABLE 105 BANOOK GROUP: BUSINESS OVERVIEW 111
11.1.5 IQVIA 112
TABLE 106 IQVIA: BUSINESS OVERVIEW 112
FIGURE 26 IQVIA: COMPANY SNAPSHOT 113
11.1.6 BIOTRIAL 115
TABLE 107 BIOTRIAL: BUSINESS OVERVIEW 115
11.1.7 CERTARA 116
TABLE 108 CERTARA: BUSINESS OVERVIEW 116
FIGURE 27 CERTARA: COMPANY SNAPSHOT 117
11.1.8 CELERION 118
TABLE 109 CELERION: BUSINESS OVERVIEW 118
11.1.9 MEDPACE 119
TABLE 110 MEDPACE: BUSINESS OVERVIEW 119
FIGURE 28 MEDPACE: COMPANY SNAPSHOT 119
11.1.10 NCARDIA 121
TABLE 111 NCARDIA: BUSINESS OVERVIEW 121
11.1.11 RICHMOND PHARMACOLOGY 122
TABLE 112 RICHMOND PHARMACOLOGY: BUSINESS OVERVIEW 122
11.1.12 PHYSIOSTIM 123
TABLE 113 PHYSIOSTIM: BUSINESS OVERVIEW 123
11.2 OTHER PLAYERS 124
11.2.1 SHANGHAI MEDICILON 124
11.2.2 PHARMACEUTICAL PRODUCT DEVELOPMENT LLC. 124
11.2.3 SGS S.A. 125
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
?
12 APPENDIX 126
12.1 DISCUSSION GUIDE 126
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 129
12.3 CUSTOMIZATION OPTIONS 131
12.4 RELATED REPORTS 131
12.5 AUTHOR DETAILS 132
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security